CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-24 | PICKERING GRANT Chief Executive Officer | Sale 10b5-1 | −11,221 | $48.96 | $549K | 374,693 |
| 2023-11-24 | PICKERING GRANT Chief Executive Officer | Sale 10b5-1 | −3,779 | $49.46 | $187K | 370,914 |
| 2023-11-20 | GUGGENHIME ANDREW President and CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 87,474 |
| 2023-11-20 | GUGGENHIME ANDREW President and CFO | Sale 10b5-1 | −7,876 | $51.12 | $403K | 79,598 |
| 2023-11-20 | GUGGENHIME ANDREW President and CFO | Sale 10b5-1 | −124 | $51.95 | $6K | 79,474 |
| 2023-11-20 | GUGGENHIME ANDREW President and CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 414,827 | ||
| 2023-11-09 | Paya Carlos V Director | Gift | −3,125 | 2,500 | ||
| 2023-11-09 | Paya Carlos V Director | Grant or award | +3,125 | 3,125 | ||
| 2023-11-09 | Paya Carlos V Director | Gift · Stock Option (right to buy) | −30,000 | 0 | ||
| 2023-11-09 | Paya Carlos V Director | Gift · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-11-09 | Paya Carlos V Director | Gift · Stock Option (right to buy) | −18,750 | 0 | ||
| 2023-11-09 | Paya Carlos V Director | Gift · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2023-11-09 | Paya Carlos V Director | Gift · Stock Option (right to buy) | −15,000 | 0 | ||
| 2023-11-09 | Paya Carlos V Director | Gift · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-11-01 | Wassil Jim Chief Operating Officer | Option exercise 10b5-1 | +3,000 | $2.42 | $7K | 178,935 |
| 2023-11-01 | Wassil Jim Chief Operating Officer | Sale 10b5-1 | −2,878 | $47.22 | $136K | 176,057 |
| 2023-11-01 | Wassil Jim Chief Operating Officer | Sale 10b5-1 | −122 | $48.12 | $6K | 175,935 |
| 2023-11-01 | Wassil Jim Chief Operating Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 99,555 | ||
| 2023-11-01 | PICKERING GRANT Chief Executive Officer | Sale 10b5-1 | −1,306 | $47.31 | $62K | 153,906 |
| 2023-11-01 | PICKERING GRANT Chief Executive Officer | Sale 10b5-1 | −3 | $48.10 | $144 | 153,903 |
Page 38 of 39 · 764 trades